Showing results (221-230 of 308) with videos related to
Sort By:
Pageof 31
Annals of Gastroenterology|September 12, 2025
Disparities in the burden of gastrointestinal diseases: a comprehensive analysis of data from randomized clinical trials from 2000-2023Wissam Ghusn, Khushboo Gala, Rudy Mrad, et al.Annals of Gastroenterology|January 3, 2017
Effects of caregiver burden on quality of life and coping strategies utilized by caregivers of adult patients with inflammatory bowel diseaseNimisha K Parekh, Shamita Shah, Kristin McMaster, et al.World Journal of Gastroenterology|November 10, 2022
Expression of the methylcytosine dioxygenase ten-eleven translocation-2 and connexin 43 in inflammatory bowel disease and colorectal cancerMohammad El-Harakeh, Jessica Saliba, Kawthar Sharaf Aldeen, et al.Digestive Diseases and Sciences|March 9, 2026
Electronic Health Record Burden Among Gastroenterology Providers in a Large Tri-state Tertiary Referral CenterAman S Bali, Saam Dilmaghani, Jana G Hashash, et al.Inflammatory Bowel Diseases|July 13, 2024
Metformin Is Associated With Improved Inflammatory Bowel Disease Outcomes in Patients With Type 2 Diabetes Mellitus: A Propensity-Matched Cohort StudyJessica C Petrov, Aakash A Desai, Gursimran S Kochhar, et al.The American Journal of Gastroenterology|July 23, 2025
ACG Clinical Guideline Update: Preventive Care in Inflammatory Bowel DiseaseFrancis A Farraye, Gil Y Melmed, Gary R Lichtenstein, et al.World Journal of Gastroenterology|June 2, 2012
A randomized open-label trial of on-demand rabeprazole vs ranitidine for patients with non-erosive reflux diseaseAbdallah A Kobeissy, Jana G Hashash, Faek R Jamali, et al.Journal of Clinical Gastroenterology|March 21, 2020
Altered Expression of the Epithelial Mucin MUC1 Accompanies Endoscopic Recurrence of Postoperative Crohn's DiseaseJana G Hashash, Pamela L Beatty, Kristen Critelli, et al.Inflammatory Bowel Diseases|June 29, 2022
Efficacy of Fecal Microbiota Transplantation in the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled TrialsNabil El Hage Chehade, Sara Ghoneim, Sagar Shah, et al.Journal of Medical Economics|May 12, 2025
Cost per remission for mirikizumab versus ustekinumab for moderately to severely active ulcerative colitis treatment from the United States commercial payer perspectiveAnkit Gulati, Neha Mittal, Sunanda Kane, et al.Pageof 31